| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2142580 | Lung Cancer | 2009 | 6 Pages |
Abstract
At predicts a better survival in patients with advanced NSCLC. The prognostic value is more stringent for stage III patients. Inclusion of At as a negative prognostic factor in the TNM staging system warrants further evaluation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mircea Dediu, Emilia Crisan, Maria Radut, Alin Tarlea, Dragos Median, Aurelia Alexandru, Georgeta Vremes, Cristian Gal,